The DOI matches its Crossref record; 153 of the 181 references it cites were found in a registry or an index; 9 of the 175 sources its claims cite were checked for support.
Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents
Open accessAbstract
Background: The Ayurvedic medicinal system employs a holistic approach to health, utilising the synergistic properties of organic resources. Research into the Ayurvedic herb Bacopa monnieri (L.) Wettst. (B.monnieri) has reported improvements in cognitive outcomes in child and adult populations. The aim of current review is to systematically assess and critically summarize clinical trials investigating B.monnieri-dominant poly-herbal formulas and their effects on the cognition, memory, learning, and behaviour in children and adolescents. Methods: Key word searches were performed using PubMed, Scopus, Cochrane Library, DHARA, and CINAHL for publications meeting inclusion criteria up to November 2017. There were no restrictions in study design. Effect sizes were calculated for all significant findings to allow for direct comparisons, and each study was evaluated on design quality. Cognitive and behavioural outcomes were grouped into validated constructs for cross-study comparison. Results: Nine trials met inclusion criteria. Five studies reported sufficient data for effect size analysis with most improvements reported in behavioural outcomes. True cognitive abilities and behavioural constructs were reviewed in six studies, with visual perception, impulsivity, and attention demonstrating the greatest improvements. The veracity of the evidence for the formulations reviewed is weakened by inconsistent statistical design and under-reporting of safety and tolerability data (44%). Conclusions: The current review extends research supporting B.monnieri as a cognitive enhancer and provides modest evidence for the use of B.monnieri in poly-herbal preparations for improving cognitive and behavioural outcomes in child and adolescent populations. Greater emphasis on statistical vigour and the reporting of tolerability data are essential for future trials to adequately document poly-herbal treatment efficacy.
Overview
CoChat Summary
TL;DR
This systematic overview assessed nine randomized trials of *Bacopa monnieri*–dominant poly-herbal formulas in children and adolescents and found modest evidence for improving cognitive and behavioural outcomes, especially visual perception, impulsivity, and attention. The authors conclude that evidence is weakened by inconsistent statistical design and poor reporting of safety and tolerability data.
Key findings
- Nine trials met inclusion criteria; all were randomized controlled trials, and all poly-herbal formulas contained *B. monnieri* as the main component.
- *B. monnieri* dosages ranged from 144 mg to 544 mg per participant per day; the average dropout rate was 9.89%, and dropouts/withdrawals were not reported in one study.
- Across cognitive and behavioural domains, the greatest improvements were reported for visual perception, impulsivity, and attention; five studies reported sufficient data for effect size analysis in the abstract, while the results section states effect size calculations were conducted on six studies.
- The average modified Jadad quality rating was 6.78 (range 5–10), and 44% of included studies did not declare any safety outcomes.
Methods
- Searches were performed in PubMed, Scopus, Cochrane Library, DHARA, Google Scholar, and CINAHL up to April 2017 (the abstract states November 2017) for trials in children/adolescents aged 4–18 using *B. monnieri*–dominant poly-herbal formulas, with no restrictions on study design.
- Inclusion criteria required randomized, double-blind, controlled design; *B. monnieri* dominant extract; no other intervention; sample size ≥20 (≥10 for crossover); intervention duration ≥1 month; measurable cognition or behaviour outcomes; and full paper in English.
- Cohen’s *d* effect sizes were calculated for significant findings; behavioural outcomes were grouped using DSM-5 ADHD constructs, cognitive outcomes using Carroll’s true cognitive ability framework, and study quality was rated with a modified Jadad Scale.
Limitations
- The authors state that only English-language studies were included, despite *B. monnieri* being native to India and likely studied in other languages, and that it was not feasible to investigate interactions or synergistic effects among the herbs.
- The authors also report that evidence is weakened by inconsistent statistical design and under-reporting of safety and tolerability data (44% of studies).
- Evident from the text: the different poly-herbal formulations make direct comparison difficult, and two studies reported only overall cognitive or behavioural scores, so individual sub-test data could not be verified and should be interpreted with caution.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
7 Valid · 1 Not valid · 46 Not checked · 26 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The benefits of B.monnieri have been well established in terms of distinct cognitive and memory improvements [1,6,7,8,14,18]”
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [1] Stough, 2008, Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial, Phytother. Res. source
- Not checked — no full text of the sourcecites [6] Downey, 2013, An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance, Phytother. Res. source
- Supportedcites [7] Benson, 2014, An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood, Phytother. Res. PTR source
In “Mood and Anxiety ratings” (page not supplied), the paper reports improved performance on cognitive tasks after Bacopa monnieri and describes memory-enhancing effects reported in earlier chronic-intervention studies. That supports the citing sentence’s broad claim about cognitive and memory benefits. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [8] Stough, 2001, The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects, Psychopharmacology source
- Partly supportedcites [14] Morgan, 2010, Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial, J. Altern. Complement. Med. sourceExperimental — accuracy not yet measured
The Introduction states that five randomized, double-blind, placebo-controlled trials 'provide evidence for its efficacy in improving cognitive performance in humans,' and the Conclusions (p. 753-759) affirm Bacopa is effective in enhancing memory performance in healthy older people (acquisition and retention), which supports the memory half of the claim. However, our copy does not treat the benefits as 'well established' across distinct cognitive domains: the Outcomes analysis and Discussion (p. 756) report significant effects only on auditory-verbal AVLT measures (trials a4, a5, a6, a7, total learning, retroactive interference), with no significant Bacopa-vs-placebo effects on visuospatial memory (CFT), visuomotor speed (TMT A and B), or subjective memory (MAC-Q), and the paper frames its own question tentatively ('Does Bacopa monnieri Improve Memory Performance in Older Persons?') within a healthy adult population aged 55+. The generalized 'well established ... distinct cognitive' portion is therefore not supported by this source. (LLM, conf=0.72)
- Not checked — no full text of the sourcecites [18] Barbhaiya, 2008, Efficacy and tolerability of bacomind® on memory improvement in elderly participants—A double blind placebo controlled study, J. Pharmacol. Toxicol. source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These findings led to further research into the cognitive decline of older adults, which demonstrated significant benefits of B.monnieri in revitalizing cortical functioning [11].”
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > 1. Introduction
What the sources say
- Partly supportedcites [11] Chaudhari, 2017, Neurocognitive effect of nootropic drug brahmi (Bacopa monnieri) in alzheimer’s disease, Ann. Neurosci. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) reports significant improvement in memory scores with Bacopa monnieri versus placebo among adults over 55 with age-associated memory impairment. It does not report that cortical functioning was measured or revitalized in those adults; its findings about the prefrontal cortex concern rats. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A number of recent studies have reported the benefits of single-extracts of B.monnieri on human cognitive function in non-clinical populations [1,6,7,8,14].”
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > 4. Discussion
What the sources say
- Not checked — no full text of the sourcecites [1] Stough, 2008, Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial, Phytother. Res. source
- Not checked — no full text of the sourcecites [6] Downey, 2013, An acute, double-blind, placebo-controlled crossover study of 320 mg and 640 mg doses of a special extract of Bacopa monnieri (CDRI 08) on sustained cognitive performance, Phytother. Res. source
- Supportedcites [7] Benson, 2014, An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood, Phytother. Res. PTR source
The Abstract reports cognitive enhancement from standardized Bacopa monnieri extracts in healthy adults and older cohorts, citing several human trials. The Mood and Anxiety ratings section also reports positive cognitive effects in this study after Bacopa monnieri administration. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [8] Stough, 2001, The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects, Psychopharmacology source
- Supportedcites [14] Morgan, 2010, Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial, J. Altern. Complement. Med. source
The Design and Participants sections describe a trial of a single Bacopa monnieri extract in healthy older adults. The Discussion (p. 756) reports that the extract significantly improved memory acquisition and retention compared with placebo. This paper is therefore one of the studies described by the citing sentence. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Complementary and alternative medicines (CAM) are fast becoming viable standalone or adjunctive treatment preferences in place of pharmaceutical treatment for a range of developmental disorders including attention-deficit/hyperactivity disorder (ADHD) [5,28,38], mental retardation [31,39], autism spectrum disorders [40], and learning disorders [41,42].”
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > 4. Discussion
What the sources say
- Not checked — no full text of the sourcecites [5] Kean, 2016, A systematic review of the ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations, Complement. Ther. Med. source
- Not checked — no full text of the sourcecites [28] Sarris, 2011, Complementary medicines (herbal and nutritional products) in the treatment of attention deficit hyperactivity disorder (adhd): A systematic review of the evidence, Complement. Ther. Med. source
- Partly supportedcites [38] Kean, 2017, Reduced inattention and hyperactivity and improved cognition after marine oil extract (pcso-524®) suppleMentation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (adhd): A randomised, double-blind, placebo-controlled trial, Psychiatrychopharmacology sourceExperimental — accuracy not yet measured
The Introduction describes growing interest in alternative treatments for ADHD and says some researchers consider fatty-acid supplements a viable alternative to medication. It also cautions that many alternative treatments lack rigorous trials. The paper does not establish that complementary and alternative medicines generally are viable adjunctive treatments for ADHD; the other disorders in the sentence have separate citations. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [31] Dave, 1993, Evaluation of BR-16a (Mentat) in cognitive and behavioural dysfunction of mentally retarded children a placebo-controlled study, Indian J. Pediatr. source
- Not matchedcites [39] Ramarao, B., Shetty, B., Srinivasan, K., Rajagoplan, V., and Indurti, J. (2011). Clinical Evaluation OF Certain Ayurvedic Formulations in the Management of Mental Retardation (Mānasa Mandatā).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [40] Amminger, 2007, Omega-3 fatty acids suppleMentation in children with autism: A double-blind randomized, placebo-controlled pilot study, Biol. Psychiatry source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The average dropout rate was 9.89%.”
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > 3. Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
32 more claims
Create a free account to see all 80 claims and to verify the 49 references still open.
- Probably not a substantial claim. 23
- It may state two separate claims as one. 29
- Not yet classified. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > 4. Discussion
“44% of the included studies not declaring any safety outcomes [29,31,33].”
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > 4. Discussion
“Four studies reported no treatment side effects experienced by the participants [29,31,33,34]”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > Abstract
“Key word searches were performed using PubMed, Scopus, Cochrane Library, DHARA, and CINAHL for publications meeting inclusion criteria up to November 2017.”
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > 2. Materials and Methods
“Pubmed, Scopus, Cochrane Library, DHARA, Google Scholar, and CINAHL were searched up to April 2017”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > Abstract
“Five studies reported sufficient data for effect size analysis”
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > 3. Results
“Effect size calculations were conducted on six studies [29,31,34,35,36,37]”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > 2. Materials and Methods
“There were no restrictions in terms of study design.”
§ Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents > 2. Materials and Methods
“Inclusion criteria: Randomised, double-blind, controlled trial design;”
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582 · cited 2×
“Finally, the methodological quality of the research article was rated using a modified Jadad Scale [27].”
MethodZhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Diagnostic and Statistical Manual of Mental Disorders(DSM)
(2008) · Encyclopedia of Counseling · doi:10.4135/9781412963978.n182 · Cited by 10,830
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Antimicrobial agents from plants: Antibacterial activity of plant volatile oils
Dorman, H. J. D., & Deans, S. G. (2000) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2000.00969.x · Cited by 4,334 · cited 1×
“Research has also found it has significant antimicrobial activity [139] as well as relieve neuropathic pain [140].”
BackgroundHuman Cognitive Abilities: A Survey of Factor-Analytic Studies
Carroll, J. B. (1993) · doi:10.1017/cbo9780511571312 · Cited by 4,121
Conners, C. K., Sitarenios, G., Parker, J. D. A., & Epstein, J. N. (1998) · Journal of Abnormal Child Psychology · doi:10.1023/a:1022602400621 · Cited by 1,772 · cited 1×
“These symptoms include hyperactivity—described as having difficulty remaining seated, fidgeting with hands or feet, excessive running, or climbing or always being on the go; inattention—described as losing things, difficulty organizing work, being easily distracted, having difficulty sustaining attention, having diffi…”
BackgroundScientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
Mishra, L. C., Singh, B. B., & Dagenais, S. (2000) · PubMed · Cited by 1,173
Pérez-Jiménez, J., Neveu, V, Vos, F., & Scalbert, A. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.221 · Cited by 798 · cited 1×
“aromaticum), or Clove, has significant antioxidant properties [137], attributed to its heightened levels of polyphenols [138].”
BackgroundClove (Syzygium aromaticum): a precious spice
Cortés-Rojas, D. F., de Souza, C. R. F., & Oliveira, W. P. (2014) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(14)60215-x · Cited by 771
Research works printed but not linked: 13
- Quadri, 1993, Mentat (BR-16a) in mentally retarded children with behavioural problems, Curr. Med. Pract., 37, 121
- Ojha, 2007, Clinical study on the role of an ayurvedic compound (manas niyamak yoga) and shirodhara in the management of adhd in children, J. Ayurveda, 1, 39
- Dutta, 2012, A study of evaluation of safety and efficacy of memomet, a multi herbal formulation (memomet) in the treatment of behavioural disorder in children, Int. J. Res. Pharm. Sci., 3, 282
- Negi, 2000, Clinical evaluation of memory enhancing properties of memory plus in children with attention deficit hyperactivity disorder, Indian J. Psychiatry, 42, 4
- Chauhan, 1993, Safety, efficacy and tolerability of Mentat in healthy male medical students: Phase-1. Placebo-controlled study, Med. Surg., 32, 11
- Goyal, 2005, Shankhpuspi (Evolvulus alsinoides Linn.): A medicinal herb, Int. J. Mendel, 22, 124
- Amin, 1961, Reaction time studies in relation to an indigenous drug-Nardostachys jatamansi, Antiseptic, 58, 565
- Sampath, 2014, A novel approach of the isolation of l-dopa from the methanolic extract of Mucuna pruriens seeds and its quantitative analysis by hptlc, Int. J. Pharmacogn. Phytochem. Res., 5, 259
- Riazunnisa, 2013, In vitro antibacterial activity and phytochemical studies of some medicinal plants, Int. J. Pharm. Sci. Rev. Res., 23, 77
- Jayaram, 2014, Antioxidant and anti-inflammatory properties of a nontoxic herbal formulation—GSTC, Int. J. PharmTech. Res., 6, 924
- Elizabeth, 2014, Evaluation of analgesic and anti-inflammatory effect of Foeniculum vulgare, Res. J. Pharm. Biol. Chem. Sci., 5, 658
- Assa, 2014, Antioxidant potential of flesh, seed and mace of nutmeg (Myristica fragrans Houtt), Int. J. ChemTech Res., 6, 2460
- Circular, F.F.a.A. (2008). A Review on Culture, Production and Use of Spirulina as Food for Humans and Feeds for Domestic Animals, Food and Agriculture Organization of the United Nations.
Cited by
Patra, J. K., Das, G., Lee, S., Kang, S., & Shin, H. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.10.001 · Cited by 170
Traditional and Herbal Medicines: Opportunities and Challenges
Saggar, S., Mir, P. A., Kumar, N., Chawla, A., Uppal, J., Shilpa, S., & Kaur, A. (2022) · Pharmacognosy Research · doi:10.5530/pres.14.2.15 · Cited by 145
Brimson, J. M., Prasanth, M. I., Plaingam, W., & Tencomnao, T. (2020) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2019.10.001 · Cited by 51
In Quest of the Mysterious Holistic Vedic Herb Bacopa monnieri (L.) Pennell
Mondal, S., Bhar, K., Mondal, P., Panigrahi, N., Sahoo, S. K., Swetha, P., Chakraborty, S., Teja, N. Y., & Parveen, N. (2023) · Pharmacognosy Research · doi:10.5530/pres.15.3.045 · Cited by 29
Sanyal, R., Nandi, S., Pandey, S., Chatterjee, U., Mishra, T., Datta, S., Prasanth, D. A., Anand, U., Mane, A. B., Kant, N., et al. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11820-6 · Cited by 27
“The plant improved cognitive and behavioral parameters in children as well as in adolescents (Kean et al. 2017).”
Retracted
Metadata
- Authors
- Kean, J., Downey, L., & Stough, C.
- Affiliations
- Swinburne University of Technology (AU)
- Austin Hospital (AU)
- Corresponding author
- Kean, James
- Venue
- Medicines
- Publisher
- MDPI AG
- Published
- 2017-11-22
- Volume
- 4
- Issue
- 4
- Pages
- 86
- ISSN
- 2305-6320 (ISSN-L)
- PMC
- PMC5750610
- OpenAlex
- W2770940293
- Semantic Scholar
- b96839b06f055a464c30a469e6137c8368bb60ae
- Cited by
- 31
- References
- 181
- Citations by year
- 2026: 5 · 2025: 4 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 1 · 2019: 7 · 2018: 2
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Medicines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
- Keywords
- Bacopa monnieri, Ayurveda, cognitive enhancement, memory, learning, behavior, children, adolescents, impulsivity, attention, visual perception, tolerability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents. https://app.cochat.ai/papers/10.3390/medicines4040086
- The paper
- Kean, J., Downey, L., & Stough, C. (2017). Systematic Overview of Bacopa monnieri (L.) Wettst. Dominant Poly-Herbal Formulas in Children and Adolescents. Medicines. https://doi.org/10.3390/medicines4040086
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
